Our science
FOR LABORATORIES &
RESEARCH PARTNERS
Empower your practice with cutting-edge screening capabilities that complement existing protocols.
Validated protocols and existing patient workflows
Technology transfer and training support
Opportunities for joint research publications
Scaleable high throughput laboratory solutions
ADVANCED MULTI-ANALYTE PLATFORM
Our platform combines multi-analyte biomarker analysis with machine-learning–based classification to investigate biological patterns associated with earlier-stage disease across multiple cancer types.
By integrating diverse circulating biomarkers beyond ctDNA alone, our approach is designed to capture a broader range of biological signals across heterogeneous cancer profiles.
ONGOING CLINICAL EVALUATION
Data derived from ongoing and/or published investigational studies
By partnering with us, you’re not only advancing next-generation early cancer detection research, but also contributing to a broader shift toward more accessible, data-driven approaches to cancer care.
CLINICAL EVIDENCE
Access our growing body of clinical research and investigational data related to blood-based early cancer detection approaches.
WHY PARTNER WITH US
ADVANCE TRANSLATIONAL CANCER RESEARCH
Explore opportunities for scientific collaboration, technology integration, and participation in ongoing translational research initiatives.